Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats

Pharmaceutical Research

Volumn 27, Issue 9, 2010, Pages 1965-1976

  Xia, Dengning ^a   Cui, Fude ^a   Piao, Hongze ^a   Cun, Dongmei ^a   Piao, Hongyu ^a   Jiang, Yanbo ^a   Ouyang, Mei ^a   Quan, Peng ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

bioavailability; dissolution; nitrendipine; oral absorption; particle size

Indexed keywords

NITRENDIPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SOLUBILITY; GASTROINTESTINAL ABSORPTION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTER SIMULATION; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROSCOPY, ELECTRON, SCANNING; MOUTH MUCOSA; NANOPARTICLES; NITRENDIPINE; PARTICLE SIZE; POWDER DIFFRACTION; RATS; RATS, WISTAR; SOLUBILITY; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 77955468781     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0200-0     Document Type: Article

References (46)

1. Shargel L, Wu-Pong S, Yu ABC. Applied biopharmaceutics & pharmacokinetics. 5th ed. New York: McGraw-Hill; 2004.
2. M Kataoka Y Masaoka Y Yamazaki T Sakane H Sezaki S Yamashita 2003 In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs Pharm Res 20 10 1674 80 10.1023/A:1026107906191 1:CAS:528:DC%2BD3sXotFClsL4%3D 14620525 (Pubitemid 37268286)
3. DM Oh RL Curl GL Amidon 1993 Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model Pharm Res 10 2 264 70 10.1023/A:1018947113238 1:CAS:528:DyaK3sXhs1SmsLw%3D 8456075 (Pubitemid 23041742)
4. GL Amidon H Lennernas VP Shah JR Crisons 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 3 414 20 10.1023/A:1016212804288
5. N Kaneniwa N Watari 1977 Dissolution of slightly soluble drugs. IV. Effect of particle size of Sulfonamides on in vitro dissolution rate and in vivo absorption rate, and their ralation to solubility Chem Pharm Bull 26 3 813 26
6. D Hörter JB Dressman 1997 Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv Drug Deliv Rev 25 1 3 14 10.1016/S0169-409X(96)00487-5 (Pubitemid 27107787)
7. A Noyes W Whitney 1897 The rate of solution of solid substances in their own solutions J Am Chem Soc 19 930 4 10.1021/ja02086a003
8. A Scholz B Abrahamsson SM Diebold E Kostewicz BI Polentarutti A-L Ungell, et al. 2001 Influence of hydrodynamics and particle size on the absorption of felodipine in labradors Pharm Res 19 1 42 6 10.1023/A:1013651215061
9. RJ Hintz KC Johnson 1989 The effect of particle size distribution on dissolution rate and oral absorption Int J Pharm 51 9 17 10.1016/0378-5173(89) 90069-0 1:CAS:528:DyaL1MXitFyqt7c%3D (Pubitemid 19087827)
10. JI Jinno N Kamada M Miyake K Yamada T Mukai M Odomi, et al. 2006 Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs J Control Release 111 56 64 10.1016/j.jconrel.2005.11.013 1:CAS:528:DC%2BD28XhslKjtL0%3D 16410029 (Pubitemid 43289995)
11. TRD Shaw JE Carless 1974 The effect of particle size on the absorption of digoxin Eur J Pharmacol 7 269 73 10.1007/BF00560343 1:CAS:528: DyaE2MXktlaqt7o%3D
12. A Hanafy H Spahn-Langguth G Vergnault P Grenier M Tubic Grozdanis T Lenhardt, et al. 2007 Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug Adv Drug Deliv Rev 59 6 419 26 10.1016/j.addr.2007.04.005 1:CAS:528:DC%2BD2sXpt1Cqtr0%3D 17566595 (Pubitemid 47260709)
13. GG Liversidge P Conzentino 1995 Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats Int J Pharm 125 2 309 13 10.1016/0378-5173(95)00148-C 1:CAS:528:DyaK2MXoslGmsbg%3D
14. L Jia H Wong C Cerna SD Weitman 2002 Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry Pharm Res 19 1091 6 10.1023/A: 1019829622088 1:CAS:528:DC%2BD38XmtlGhurc%3D 12240933 (Pubitemid 34984991)
15. AJ Jounela PJ Pentikäìinen A Sothmann 1975 Effect of particle size on the bioavailability of digoxin Eur J Clin Pharmacol 8 365 70 10.1007/BF00562664 1:CAS:528:DyaE2MXlsFahuro%3D 1233237
16. F Kesisoglou Y Wu 2008 Understanding the effect of API properties on bioavailability through absorption modeling AAPS J 10 4 516 25 10.1208/s12248-008-9061-4 1:CAS:528:DC%2BD1MXltVSls74%3D 19002590
17. Avdeef A. Absorption and drug development: solubility, permeability, and charge state. Hoboken: Wiley; 2003.
18. PA Soons DD Breimer 1991 Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects Br J Clin Pharmacol 32 11 6 1:CAS:528:DyaK3MXlvFOlt7s%3D 1888628
19. Sweetman SC, Blake PS. Martindale: the complete drug reference. 36th ed. London•Chicago: Pharmaceutical Press; 2009.
20. D Xia P Quan H Piao H Piao S Sun Y Yin, et al. 2010 Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability Eur J Pharm Sci 40 4 325 34 10.1016/j.ejps.2010.04.006 1:CAS:528:DC%2BC3cXmslOhtbo%3D 20417274
21. R Löbenberg J Krämer VP Shah GL Amidon JB Dressman 2000 Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide Pharm Res 17 4 439 44 10.1023/A:1007529020774 10870988 (Pubitemid 30395299)
22. Dressman JB, Lennernäs H. Oral drug absorption: prediction and assessment. New York•Basel: Marcel Dekker, Inc; 2000.
23. F Langenbucher 2003 Handling of computational in vitro/in vivo correlation problems by Microsoft Excel: III. Convolution and deconvolution Eur J Pharm Biopharm 56 3 429 37 10.1016/S0939-6411(03)00140-1 1:CAS:528: DC%2BD3sXos12qurc%3D 14602187 (Pubitemid 37346517)
24. Perrier D, Gibaldi M. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc; 1982.
25. AT Lu ME Frisella KC Johnson 1993 Dissolution modeling: factors affecting the dissolution rates of polydisperse powders Pharm Res 10 9 1308 14 10.1023/A:1018917729477 1:CAS:528:DyaK3sXmtleqsLk%3D 8234168 (Pubitemid 23261831)
26. K Nakanishi 1978 Prediction of diffusion coefficient of nonelectrolytes in dilute solution based on generalized hammond-stokes plot Ind Eng Chem Fundam 17 4 253 6 10.1021/i160068a004 1:CAS:528:DyaE1cXlsFartb8%3D
27. L Cantrel 1997 Diffusion coefficients of molecular iodine in aqueous solutions J Chem Eng Data 42 1 216 20 10.1021/je960178u 1:CAS:528: DyaK2sXitVKksg%3D%3D
28. Poling BE, Prausnitz JM, O'Connell JP. Properties of gases and liquids. 5th ed. New York: McGraw-Hill; 2000.
29. Brown CK, Chokshi HP, Nickerson B, Reed RA, Rohrs BR, Shah PA. Acceptable analytical practices for dissolution testing of poorly soluble compounds. Pharm Technol. 2004;28(12):56-65.
30. F Kesisoglou S Panmai Y Wu 2007 Nanosizing-oral formulation development and biopharmaceutical evaluation Adv Drug Deliv Rev 59 631 44 10.1016/j.addr.2007.05.003 1:CAS:528:DC%2BD2sXpsFGks7o%3D 17601629 (Pubitemid 47285408)
31. Müller RH, Benita S, Böhm BHL. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Stuttgart: Medpharm Scientific Publishers; 1998.
32. Qiu Y, Chen Y, Zhang GGZ. Developing solid oral dosage forms: pharmaceutical theory and practice. Burlington: Academic; 2009.
33. N Kaneniwa N Watari H Iijima 1978 Dissolution of slightly soluble drugs.V. Effect of particle size on gastrointestinal drug absorption and its relation to solubility Chem Pharm Bull 26 9 2603 14 1:CAS:528: DyaE1MXht1aitg%3D%3D 699204
34. Ehrhardt C, Kim K-J. Drug absorption studies: in situ, in vitro and in silico models. New York: Springer; 2008.
35. L Bønløkke L Hovgaard HG Kristensen L Knutson H Lennernäs 2001 Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut®) in humans Eur J Pharm Sci 12 3 239 50 10.1016/S0928-0987(00)00138-X 11113643
36. JB Dressman C Reppas 2000 In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs Eur J Pharm Sci 11 Supplement 2 S73 80 10.1016/S0928-0987(00)00181-0 1:CAS:528:DC%2BD3cXntF2gtbY%3D 11033429
37. Augustijns P, Brewster ME. Solvent systems and their selection in pharmaceutics and biopharmaceutics. New York: Springer; 2007.
38. A Lamprecht U Schafer CM Lehr 2001 Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa Pharm Res 18 6 788 93 10.1023/A:1011032328064 1:CAS:528:DC%2BD3MXlt1Cqtbs%3D 11474782 (Pubitemid 32783514)
39. G Ponchel J-M Irache 1998 Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract Adv Drug Deliv Rev 34 2-3 191 219 10.1016/S0169-409X(98)00040-4 1:CAS:528: DyaK1cXnsFWlt78%3D 10837678 (Pubitemid 28535112)
40. Y Yin D Chen M Qiao X Wei H Hu 2007 Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution J Control Release 123 1 27 38 10.1016/j.jconrel.2007.06.024 1:CAS:528: DC%2BD2sXhtV2qsLnF 17728000 (Pubitemid 47444385)
41. MA Arangoa G Ponchel AM Orecchioni MJ Renedo D Duchêne JM Irache 2000 Bioadhesive potential of gliadin nanoparticulate systems Eur J Pharm Sci 11 4 333 41 10.1016/S0928-0987(00)00121-4 1:CAS:528:DC%2BD3cXntF2gtLc%3D 11033077
42. G Ponchel M-J Montisci A Dembri C Durrer D Duchêne 1997 Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract Eur J Pharm Biopharm 44 1 25 31 10.1016/S0939-6411(97)00098-2 1:CAS:528: DyaK2sXmtFShtr0%3D (Pubitemid 28298772)
43. NA Peppas PJ Hansen PA Buri 1984 A theory of molecular diffusion in the intestinal mucus Int J Pharm 20 1-2 107 18 10.1016/0378-5173(84)90222-9 1:CAS:528:DyaL2cXlt1ams7c%3D
44. C Durrer JM Irache F Puisieux D Duchêne G Ponchel 1994 Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies Pharm Res 11 5 680 3 10.1023/A:1018920128007 1:CAS:528:DyaK2cXjtVOgtrk%3D 8058636 (Pubitemid 24171762)
45. D Scherrer FC Mooren RKH Kinne J Kreuter 1993 In vitro permeability of PBCA nanoparticles through porcine small intestine J Drug Target 1 1 21 8 10.3109/10611869308998761
46. C Damgè C Michel M Aprahamian P Couvreur JP Devissaguet 1990 Nanocapsules as carriers for oral peptide delivery J Control Release 13 233 9 10.1016/0168-3659(90)90013-J